301
Participants
Start Date
March 28, 2017
Primary Completion Date
February 24, 2020
Study Completion Date
December 30, 2025
Durvalumab
MEDI4736
Tremelimumab
Tremelimumab
Platinum-Based Drug
Pemetrexed, cisplatin, carboplatin or gemcitibine
Prince of Wales Hospital, Randwick
Concord Repatriation General Hospital, Concord
Liverpool Cancer Therapy Centre, Liverpool Hospital, Liverpool
St. George Hospital, Cancer Care Centre, Kogarah
Coffs Habour Health Campus - NCCI, Coffs Harbour
The Tweed Hospital, Lismore
Campbelltown Hospital, Campbelltown
Nepean Hospital, Kingswood
St. Vincent's Hospital, Victoria Park
Epworth HealthCare - Richmond, Richmond
Ballarat Health Services, Ballarat
Border Medical Oncology, Wodonga
The Prince Charles Hospital, Chermside
Mater Research Institute South Brisbane, South Brisbane
Princess Alexandra Hospital, Brisbane
Gold Coast University Hospital, Southport
Toowoomba Hospital, Toowoomba
Saint John of God Hospital Subiaco, Subiaco
Royal Hobart Hospital, Hobart
Cross Cancer Institute, Edmonton
BCCA - Fraser Valley Cancer Centre, Surrey
BCCA - Vancouver Cancer Centre, Vancouver
Horizon Health Network, Fredericton
The Moncton Hospital, Moncton
The Vitalite Health Network - Dr. Leon Richard, Moncton
Regional Health Authority B, Zone 2, Saint John
Cambridge Memorial Hospital, Cambridge
Health Sciences North, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Kingston Health Sciences Centre, Kingston
Grand River Regional Cancer Centre, Kitchener
Stronach Regional Health Centre at Southlake, Newmarket
Ottawa Hospital Research Institute, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Niagara Health System, St. Catharines
North York General Hospital, Toronto
Humber River Regional Hospital, Toronto
Michael Garron Hospital, Toronto
University Health Network, Toronto
Windsor Regional Cancer Centre, Windsor
PEI Cancer Treatment Centre, Charlottetown
Hopital de la Cite-de-la-Sante, Laval
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal
The Jewish General Hospital, Montreal
CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec
University Institute of Cardiology and, Québec
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Collaborators (1)
AstraZeneca
INDUSTRY
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OTHER
National Health and Medical Research Council, Australia
OTHER
Canadian Cancer Trials Group
NETWORK